OK Biotech Co., Ltd. (4155.TW)
TWD 20.9
(-0.71%)
TWD 20.9
(-0.71%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.19 Billion | 1.48 Billion | 1.26 Billion | 1.48 Billion | 1.24 Billion | 1.12 Billion |
| Cost of Revenue | 995.1 Million | 1.13 Billion | 1.07 Billion | 1.15 Billion | 945.12 Million | 818.23 Million |
| Gross Profit | 196.88 Million | 344.95 Million | 186.82 Million | 325.95 Million | 296.12 Million | 302.1 Million |
| Operating Expenses | 216.37 Million | 204.82 Million | 176.97 Million | 189.53 Million | 187.14 Million | 160.38 Million |
| Selling, General and Administrative Expenses | 148.4 Million | 156.09 Million | 148.24 Million | 152.14 Million | 156.53 Million | 127.23 Million |
| Research and Development Expenses | 46.71 Million | 48.73 Million | 28.73 Million | 45.46 Million | 32.56 Million | 40.79 Million |
| Other Expenses | 1.76 Million | 60.89 Million | 13.84 Million | -8.07 Million | -1.94 Million | 34.29 Million |
| Cost and Expenses | 1.2 Billion | 1.34 Billion | 1.25 Billion | 1.34 Billion | 1.13 Billion | 978.62 Million |
| Operating Income | -12.06 Million | 211.62 Million | 49.31 Million | 170.09 Million | 147.47 Million | 141.72 Million |
| Interest Expense | 8.99 Million | 11.42 Million | 8.07 Million | 8.12 Million | 6.11 Million | 5.3 Million |
| Income Tax Expense | 9.62 Million | 38.86 Million | 14.71 Million | 30.35 Million | 30.69 Million | 41.08 Million |
| Earnings before Tax | 8.02 Million | 175.59 Million | 46.14 Million | 151.65 Million | 143.37 Million | 201.59 Million |
| Net Income | 2.94 Million | 143.46 Million | 31.42 Million | 129.72 Million | 125.76 Million | 161.36 Million |
| Earnings Per Share Basic | 0.02 | 1.34 | 0.30 | 1.39 | 1.49 | 2.04 |
| Earnings Per Share Diluted | 0.02 | 1.14 | 0.26 | 1.30 | 1.42 | 2.04 |
| Weighted Average Shares Outstanding | 128.23 Million | 106.68 Million | 105.89 Million | 93.15 Million | 84.45 Million | 79.01 Million |
| Weighted Average Shares Outstanding (Diluted) | 128.4 Million | 132.38 Million | 120.4 Million | 101.31 Million | 89.31 Million | 79.01 Million |
| Gross Margin | 0.17 | 0.23 | 0.15 | 0.22 | 0.24 | 0.27 |
| EBIT Margin | 0.07 | 0.19 | 0.08 | 0.15 | 0.15 | 0.22 |
| Profit Margin | 0.00 | 0.10 | 0.02 | 0.09 | 0.10 | 0.14 |
| EBITDA | 87.24 Million | 247.47 Million | 85.45 Million | 171.23 Million | 164.34 Million | 201.69 Million |
| Earnings Before Tax Margin | -0.01 | 0.14 | 0.04 | 0.11 | 0.12 | 0.13 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 435.91 Million | 352.27 Million | 1.19 Billion | 273.82 Million | 275.7 Million | 319.38 Million |
| Cost of Revenue | 339.05 Million | 308.86 Million | 987.67 Million | 247.96 Million | 241.85 Million | 251.76 Million |
| Gross Profit | 96.86 Million | 43.41 Million | 204.31 Million | 25.86 Million | 33.84 Million | 67.62 Million |
| Operating Expenses | 65.52 Million | 30.62 Million | 216.37 Million | 41.04 Million | 37.97 Million | 56.4 Million |
| Selling, General and Administrative Expenses | 56.85 Million | 38.71 Million | - | 34.66 Million | 30.94 Million | 42.58 Million |
| Research and Development Expenses | 8.66 Million | 13.81 Million | - | 16.14 Million | 7.02 Million | 13.81 Million |
| Other Expenses | 13.56 Million | -30.62 Million | -216.37 Million | -41.04 Million | 22.16 Million | 20.47 Million |
| Cost and Expenses | 404.57 Million | 339.49 Million | 1.2 Billion | 289 Million | 279.82 Million | 308.17 Million |
| Operating Income | 31.34 Million | 12.78 Million | -12.06 Million | -15.18 Million | 19.4 Million | 37.8 Million |
| Interest Expense | 1.43 Million | 1.49 Million | 8.99 Million | 1.47 Million | 1.81 Million | 2.39 Million |
| Income Tax Expense | 5.79 Million | 8.8 Million | 9.62 Million | -6.13 Million | 648 Thousand | 10.2 Million |
| Earnings before Tax | 48.69 Million | 47.7 Million | 8.02 Million | -37.23 Million | -272 Thousand | 23.19 Million |
| Net Income | 42.26 Million | 36.1 Million | -1.59 Million | -31.1 Million | 832 Thousand | 15.06 Million |
| Earnings Per Share Basic | 0.29 | 0.25 | - | -0.21 | 0.01 | 0.12 |
| Earnings Per Share Diluted | 0.28 | 0.24 | - | -0.21 | 0.01 | 0.12 |
| Weighted Average Shares Outstanding | 147.02 Million | 144.4 Million | 128.23 Million | 145.76 Million | 129.41 Million | 128.78 Million |
| Weighted Average Shares Outstanding (Diluted) | 150.18 Million | 150.42 Million | 128.4 Million | 145.76 Million | 129.41 Million | 135.2 Million |
| Gross Margin | 0.22 | 0.12 | 0.17 | 0.09 | 0.12 | 0.21 |
| EBIT Margin | 0.11 | 0.11 | - | -0.11 | 0.14 | 0.18 |
| Profit Margin | 0.10 | 0.10 | -0.00 | -0.11 | 0.00 | 0.05 |
| EBITDA | 48.09 Million | 39.84 Million | - | -29.56 Million | 38.4 Million | 57.26 Million |
| Earnings Before Tax Margin | 0.07 | 0.04 | -0.01 | -0.06 | 0.07 | 0.12 |
ALEO2
0078
603298
5313
1MO
600038